JP2005500390A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500390A5
JP2005500390A5 JP2003521814A JP2003521814A JP2005500390A5 JP 2005500390 A5 JP2005500390 A5 JP 2005500390A5 JP 2003521814 A JP2003521814 A JP 2003521814A JP 2003521814 A JP2003521814 A JP 2003521814A JP 2005500390 A5 JP2005500390 A5 JP 2005500390A5
Authority
JP
Japan
Prior art keywords
kgf
pharmaceutical composition
amino acid
composition according
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003521814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/026929 external-priority patent/WO2003016505A2/en
Publication of JP2005500390A publication Critical patent/JP2005500390A/ja
Publication of JP2005500390A5 publication Critical patent/JP2005500390A5/ja
Pending legal-status Critical Current

Links

JP2003521814A 2001-08-21 2002-08-21 Ｋｇｆポリペプチド組成物 Pending JP2005500390A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31388101P 2001-08-21 2001-08-21
PCT/US2002/026929 WO2003016505A2 (en) 2001-08-21 2002-08-21 Kgf polypeptide compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009119866A Division JP2009221207A (ja) 2001-08-21 2009-05-18 Ｋｇｆポリペプチド組成物

Publications (2)

Publication Number Publication Date
JP2005500390A JP2005500390A (ja) 2005-01-06
JP2005500390A5 true JP2005500390A5 (enExample) 2006-01-05

Family

ID=23217561

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003521814A Pending JP2005500390A (ja) 2001-08-21 2002-08-21 Ｋｇｆポリペプチド組成物
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Ｋｇｆポリペプチド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Ｋｇｆポリペプチド組成物

Country Status (8)

Country Link
US (2) US7265089B2 (enExample)
EP (1) EP1429799A4 (enExample)
JP (2) JP2005500390A (enExample)
AU (1) AU2002326742B2 (enExample)
CA (1) CA2457781A1 (enExample)
MX (1) MXPA04001526A (enExample)
PL (1) PL374269A1 (enExample)
WO (1) WO2003016505A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4219708A3 (en) * 2009-07-17 2023-10-11 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
CA2928526A1 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2153816T3 (es) 1989-01-31 2001-03-16 Jeffrey S Rubin Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5655870A (en) * 1993-03-01 1997-08-12 Kawasaki Steel Corporation Stacker crane in a warehouse
US5965530A (en) 1993-03-26 1999-10-12 Amgen Inc. Therapeutic uses of keratinocyte growth factor
CZ343795A3 (en) 1993-06-29 1996-07-17 Chiron Corp Shortened keratinocyte growth factor /kgf/ exhibiting increased biological activity
PT785950E (pt) 1994-10-13 2003-09-30 Amgen Inc Analogos do factor de crescimento de queratinocitos
DK0785949T3 (da) 1994-10-13 2003-08-18 Amgen Inc Fremgangsmåde til oprensning af keratinocytvækstfaktorer
CZ297328B6 (cs) * 1994-10-13 2006-11-15 Amgen Inc. Amgen Center Analog nativního keratinocytového rustového faktoru, zpusob jeho výroby a pouzití, farmaceutický prostredek, kit, nukleová kyselina, vektor, hostitelská bunka a in vitro zpusob stimulace produkce epithelových bunek
US5841605A (en) * 1996-11-06 1998-11-24 Iomega Corporation Caddy for cartridge and disk drive accomodating a caddy
EP1012186B1 (en) * 1996-12-06 2002-07-17 Amgen Inc., Use of a kgf protein product(s) and a glp-2 protein product(s) for the preparation of a medicament

Similar Documents

Publication Publication Date Title
JP2001520238A5 (enExample)
RU95113418A (ru) Полипептиды, способы получения, днк, вектор, клетка, применение полипептида, фармацевтические композиции
US5693616A (en) Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
JP2004536077A5 (enExample)
JP2008507298A5 (enExample)
HRP20110242T1 (hr) Formulacija s fuzijskim proteinom glp-1-fc
EP1778842B8 (en) Compositions and methods of use for mgd-csf in disease treatment
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2009525052A5 (enExample)
JP2002528060A5 (enExample)
RU2007110981A (ru) Урокортин iii и его использование
JP2015057058A (ja) 組織傷害の修復におけるストロマ細胞由来因子１のプロテアーゼ耐性変異体
JP2004531242A5 (enExample)
JP2012508698A5 (enExample)
JP2007535910A5 (enExample)
WO1995002610A1 (en) Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
JP2005500390A5 (enExample)
JP2006514111A5 (enExample)
JP2004513079A5 (enExample)
JP2004532037A5 (enExample)
JPH03504501A (ja) 両親媒性ペプチドとその用途
JP2007536910A5 (enExample)
JP2004521076A5 (enExample)
JP2004533846A5 (enExample)